✦ LIBER ✦

Specific and non-specific immunologic mechanisms of tumor growth facilitation

✍ Scribed by Hisakazu Yamagishi; Neal R. Pellis; Margalit B. Mokyr; Dr. Barry D. Kahan

Publisher: John Wiley and Sons
Year: 1980
Tongue: English
Weight: 464 KB
Volume: 45
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19800615)45:12<2929::aid-cncr2820451205>3.0.co;2-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor-suppressive activity of the growth

Tumor-suppressive activity of the growth arrest-specific gene GAS1 in human tumor cell lines

✍ Andreas Evdokiou; Prudence A. Cowled 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 261 KB 👁 2 views

The GAS1 gene product induces growth arrest through a p53-dependent mechanism. To investigate whether GAS1 is a tumor suppressor gene, we transfected GAS1-negative human tumor cells with GAS1 plasmids and analyzed growth characteristics of stable transfectants. When a constitutively expressing GAS1

Inhibition of human tumor cell growth In

Inhibition of human tumor cell growth In vitro and In vivo by a specific inhibitor of human farnesyltransferase: BIM-46068

✍ Grégoire P. Prevost; Anne Pradines; Isabelle Viossat; Marie-Christine Brezak; Ka 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 69 KB 👁 1 views

Recombinant antibody toxins specific for

Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo

✍ Marc Azemar; Mathias Schmidt; Friederike Arlt; Pierre Kennel; Burkhard Brandt; A 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 130 KB 👁 2 views

## Overexpression of the ErbB2 and epidermal growth factor receptor (EGFR) tyrosine kinases is frequently observed in squamous cell carcinomas of the head and neck, and has been correlated with shorter overall survival. By immunoblot analysis, we have found EGFR and ErbB2 expression in 6 out of 6 e

CD80 expression in an HLA-A2-positive hu

CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancer

✍ Dale L. Bixby; John R. Yannelli 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 185 KB 👁 2 views

To generate non-small cell lung cancer (NSCLC)-reactive lymphocytes, we transfected an HLA-A2-expressing human NSCLC line (1355) with the cDNA encoding the lymphocyte co-stimulatory molecule CD80. Following selection in G418, 1355.7 demonstrated stable cell-surface expression of CD80. Allogeneic mix